Sector revisions Imexpharm Corporation

Stocks

End-of-day quote Ho Chi Minh S.E. 2026-09-10			5-day change	1st Jan Change
38,100.00 ^VND	-1.80%		-4.27%	-27.43%

07-19	Imexpharm Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
07-01	Imexpharm Corporation Announces Cash Dividend for the Year 2025, Payable on July 21, 2026	CI

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Visibility	Nbr of analysts
IMEXPHARM CORPORATION	-	1
ELI LILLY AND COMPANY		29
JOHNSON & JOHNSON		22
ABBVIE INC.		29
ROCHE HOLDING AG		19
NOVARTIS AG		22
ASTRAZENECA PLC		23
AMGEN INC.		29
NOVO NORDISK A/S		23
GILEAD SCIENCES, INC.		27
PFIZER INC.		26
VERTEX PHARMACEUTICALS INCORPORATED		26
BRISTOL-MYERS SQUIBB COMPANY		24
SANOFI		24
GSK PLC		21
CHUGAI PHARMACEUTICAL CO., LTD.		15
TAKEDA PHARMACEUTICAL COMPANY LIMITED		16
BAYER AG		18
JIANGSU HENGRUI PHARMACEUTICALS CO.,LTD		17
TEVA PHARMACEUTICAL INDUSTRIES LIMITED		11
Average		21
Weighted average by Cap.		25

40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!